Short Summary
Topotarget UK Limited appealed a rejection order against its patent application for a pharmaceutical composition (PXD101 with an in situ salt former). The rejection was based on insufficiency of disclosure, lack of inventive step, and Section 3(d) objections. The High Court found that the Controller misconstrued the invention as a salt per se, failing to consider the multi-component nature of the composition.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Calcutta High Court. Understanding the court's reasoning in Topotarget Uk Limited vs The Controller General Of Patent And Designs, Mumbai and Ors. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Jupeng Bio (Hk) LimitedvsThe Controller of Patents and Designs, Government of India
Jupeng Bio appealed an order rejecting its patent application for 'Control of Conductivity in Anaerobic Fermentation'. The appellant challenged the rejection, arguing that the prior art cited did not explicitly disclose all claimed elements (conductivity and SCU relationship), and that the reasons for rejection under Section 3(d) were unreasoned. The High Court found deficiencies in the respondent's reasoning regarding both novelty and Section 3(d) non-patentability.
Bayer Healthcare LlcvsMSN Laboratories Private Limited
This order addressed various interlocutory applications in the commercial suit filed by Bayer Healthcare Llc against MSN Laboratories Private Limited. The court allowed several procedural requests, including granting time extensions and allowing additional documents. It also noted that the defendant had not yet launched its product and directed it to maintain status quo.
Rxprism Health Systems Private LimitedvsCanva Pty Ltd
Rxprism Health Systems Private Limited filed a suit seeking an injunction against Canva Pty Ltd, alleging infringement of its Indian Patent No. IN 360726, which covers a system and method for creating and sharing interactive content. The Plaintiff argued that Canva's 'Present and Record' feature directly infringes the patented technology used in their product, 'My Show & Tell'. After analyzing the claims and evidence, the Delhi High Court found prima facie merit in the Plaintiff's case.
Bia Separations D.O.O.vsAssistant Controller of Patents and Designs, Government of India
Bia Separations D.O.O. appealed the rejection of its Patent Application No.185/CHENP/2009 for 'METHOD FOR INFLUENZA VIRUS PURIFICATION'. The appeal challenged the Controller's finding that the invention lacked inventive step under Section 2(1)(ja) of the Patents Act, 1970.
Alone TrustvsUnion of India and others
This Public Interest Litigation addressed the persistent issue of improper use of the State Emblem of India in various fields, particularly trade and commerce. The court recognized that despite existing legislation like the Emblems and Names (Prevention of Improper Use) Act, 1950, misuse continued due to a lack of public awareness. Consequently, the High Court issued comprehensive directions to the State Government of Odisha to establish a Task Force, create SOPs, and develop an online reporting portal to ensure responsible usage.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.